Pages
New study details the costs and benefits of Medicaid
Gigi Douban May 2, 2013
In Oregon, researchers followed 10,000 new enrollees in Medicaid. They used more health care services, but had more to spend on other necessities.
New forms hope to make it easier to sign up for health insurance
David Gura May 1, 2013
Federal health agency releases shorter, less confusing applications for health care reform programs.
California bets big on marketing to spread the health care gospel
Aarti Shahani Apr 25, 2013
Millions of Californians will be eligible for healthcare under the new law, and lots of them know nothing about it.
Genetics may be the next big thing in medicine, but at what cost?
Dan Gorenstein Apr 12, 2013
Many believe genetics are the next big thing in medicine, but one question for this new era of personalized medicine is cost.
What if you got less Social Security if you didn't need it as much?
Krissy Clark Apr 12, 2013
Current recipients have different reactions. Some scholars say basing the amount of payments on need could make the program less popular.
'Chained CPI' hurts seniors
Robert Reich Apr 10, 2013
Obama's proposal to recalculate the rate of inflation hurts seniors who spend more on health care than the rest of us.
Bush adviser Glenn Hubbard on how to make entitlement reform fair
Jeremy Hobson Apr 9, 2013
Glenn Hubbard, former Chair of the White House Economic Council of Advisers under President George W. Bush, discusses the entitlement reform, the economic recovery, and taxes.
Dementia is highest cost disease and rising
Dan Gorenstein Apr 4, 2013
A report in the latest issue of the New England Journal of Medicine says the U.S. spends more on treating dementia than any other disease including cancer and heart disease.
Nursing exams keep pace with health care tech advances
Kate Casey Apr 2, 2013
It helps to be up on the latest tech if you want to be a registered nurse. This week the National Council of State Boards of Nursing is rolling out a new update to its nurse licensing exam.
India Novartis patent ruling: Good for access, bad for innovation?
Dan Gorenstein Apr 1, 2013
India's Supreme Court has rejected a patent filed by Swiss drug maker Novartis for its cancer drug. The decision has implications for the pharmaceutical industry and millions of people in poor countries.
